Pediatric Alliance for International Neurogastrointestinal Functional Research
NCT ID: NCT01099787
Last Updated: 2018-07-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
348 participants
OBSERVATIONAL
2010-04-30
2017-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To assess the natural history of pain predominant functional gastrointestinal disorders (FGID) in newly diagnosed pediatric patients.
To document the benefit of various treatment regimens currently employed in managing FGID.
To assess the short- and long-term impact of various FGID regimens.
To allow physicians to gain a better understanding of the epidemiology of FGID.
Hypothesis:
There are presenting symptoms or results from diagnostic tests that are more likely to associated with conditions different from FAP or IBS.
Symptoms of children with FAP/IBS change overtime regardless of the treatments used.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Functional Gastrointestinal Disorders in Pediatric IBD
NCT03565263
Efficacy of Open Label Placebo in Children With FGIDs
NCT02389998
The Association of Clinical Symptom Clusters With Underlying Mechanisms in Functional Gastrointestinal Disorders
NCT04331223
Delivered Dietary Intervention for Children With Irritable Bowel Syndrome
NCT01339117
Pain in Pediatric Patients - Internet Interventions for Disorders of Gut-brain Interaction
NCT07319078
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
FAP IBS
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Presenting with chronic or intermittent abdominal pain of any severity lasting at least 2 months may participate in the Registry.
Exclusion Criteria
* Patients unable to participate in the program for at least 3 years should not be enrolled (i.e., anticipated move, etc.)
4 Years
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nationwide Children's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Carlo Di Lorenzo
Professor of Clinical Pediatrics
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carlo Di Lorenzo, M.D.
Role: PRINCIPAL_INVESTIGATOR
Nationwide Children's Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Connecticut Children's Hospital
Hartford, Connecticut, United States
Childrens Memorial Hospital
Chicago, Illinois, United States
LSU Health Sciences Center
New Orleans, Louisiana, United States
Children's Hospital Boston
Boston, Massachusetts, United States
Nationwide Children's Hospital
Columbus, Ohio, United States
Children's Hospital of Wisconsin
Milwaukee, Wisconsin, United States
Emma Children's Hospital
Amsterdam, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB10-00022
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.